Keler et al., 1989 - Google Patents
Effects on growth and energy metabolism in untransformed and transformed BALB/c mouse fibroblasts by a novel cytotoxic compoundKeler et al., 1989
- Document ID
- 902247490774805049
- Author
- Keler T
- Smith C
- Publication year
- Publication venue
- Cancer research
External Links
Snippet
A lipid, recently discovered as a contaminant of endotoxin and White-Type polysaccharide preparations from an unidentified isolate of Serratia marcescens, was named DCX for its direct cytotoxic activity. Previously we have shown that DCX is cytotoxic to several …
- 230000000694 effects 0 title abstract description 40
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/11—Aldehydes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Gelderblom et al. | Structure-activity relationships of fumonisins in short-term carcinogenesis and cytotoxicity assays | |
| Freudenberg et al. | Requirement for lipopolysaccharide-responsive macrophages in galactosamine-induced sensitization to endotoxin | |
| Churchill et al. | Agent of Marek's disease in tissue culture | |
| Pierce et al. | Infection of mice with mammalian tubercle bacilli grown in Tween-albumin liquid medium | |
| Holtermann et al. | Selective cytotoxicity of peritoneal leucocytes for neoplastic cells | |
| EP0163475A2 (en) | Immunoregulation | |
| Zhang et al. | Laboratory studies of berberine used alone and in combination with 1, 3-bis (2-chloroethyl)-1-nitrosourea to treat malignant brain tumors | |
| Robbana-Barnat et al. | Immunosuppressive properties of deoxynivalenol | |
| JP2016539184A (en) | Algal extract for use as an immunomodulator | |
| Matalon et al. | Glycolipid and mucopolysaccharide abnormality in fibroblasts of Fabry's disease | |
| Borland et al. | Early appearance of “transformed” cells from the kidneys of rats treated with a “single” carcinogenic dose of dimethylnitrosamine (DMN) detected by culture in vitro | |
| Lazzarini-Robertson JR | Effects of heparin on the uptake of lipids by isolated human and animal arterial endothelial type cells | |
| Tang et al. | Marijuana and immunity: tetrahydrocannabinol-mediated inhibition of growth and phagocytic activity of the murine macrophage cell line, P388D1 | |
| Rice et al. | Effect of cytochalasins on surfactant release from alveolar type II cells | |
| Olden et al. | Selective cytotoxicity of tunicamycin for transformed cells | |
| Sakagami et al. | Partial purification of novel differentiation-inducing substance (s) from hot water extract of Japanese pine cone | |
| Keler et al. | Effects on growth and energy metabolism in untransformed and transformed BALB/c mouse fibroblasts by a novel cytotoxic compound | |
| Schmitt et al. | Toxicologic evaluation of Cellulon™ fiber; genotoxicity, pyrogenicity, acute and subchronic toxicity | |
| EP0997473B1 (en) | Natural antitumor or antiviral substances and use of the same | |
| Zuckerman et al. | Effects of actinomycin D in vivo on murine erythroid stem cells | |
| Soldo | Cultivation of two strains of killer Paramecium aurelia in axenic medium. | |
| KR100535266B1 (en) | Scrophularia buergeriana extract with anti-aging activity and a composition containing the extract | |
| JPWO1998055493A1 (en) | Natural antitumor or antiviral substances and their uses | |
| KR20010111569A (en) | High molecular weight extracts of Convolvulus arvensis(field bindweed) | |
| Ochiai et al. | Inhibition of experimental pulmonary metastasis in mice by β-cyclodextrin-benzaldehyde |